α-Onocerin: An acetylcholinesterase inhibitor from Lycopodium clavatum

Planta Medica

Volumn 69, Issue 3, 2003, Pages 265-267

  Orhan, Ilkay ^a   Terzioglu, Salih ^b   Şener, Bilge ^a  

^a GAZI UNIVERSITY   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ONOCERIN; CHOLINESTERASE INHIBITOR; DONEPEZIL; LYCOPODIUM CLAVATUM EXTRACT; PLANT EXTRACT; RIVASTIGMINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; BIOAVAILABILITY; CAUSE OF DEATH; DRUG ISOLATION; ENZYME INHIBITION; LIVER TOXICITY; SPECTROPHOTOMETRY; STRUCTURE ANALYSIS;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; HUMANS; LYCOPODIUM; PHYTOTHERAPY; PLANT EXTRACTS; TRITERPENES;

HUPERZIA SELAGO SELAGO; LYCOPODIACEAE; LYCOPODIUM ALPINUM; LYCOPODIUM ANNOTINUM; LYCOPODIUM CLAVATUM; LYCOPODIUM COMPLANATUM; SELAGO;

EID: 0344520514     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38489     Document Type: Article

References (20)

1. Adams RL, Craig PL, Parsons OA. Neuropsychology of dementia. Neurolog Clin 1984; 4: 387-405
2. Aisen PS, Davis KL. The search for disease-modifying treatment for Alzheimer's disease. Neurology 1997; 48: 35-41
3. Bachman DL, Wolf PA, Linn RT, Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 1992; 42: 115-9
4. Schneider LS. Treatment of Alzheimer's disease with cholinesterase inhibitors. Clin. Geriatr. Med. 2001; 17: 337-9
5. Guardado-Santervas P. Controversy Surrounding new drugs for the treatment of dementia. An unfavorable view. Rev. Neurologia 2001; 32: 172-5
6. Gauthier S. Alzheimer's disease: current and future therapeutic perspectives. Prog Neuro-Psychoph 2001; 25: 73-89 (2001)
7. Davis KL, Mobs RS. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Am J Psychiatry 1982; 139: 1421-4
8. Shaw H, Bentley G. Anticholinesterase properties of tetrahydroaminoacridine. Aust J Exp Biol 1953; 31: 573-8
9. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Meth & Find & Clin Pharmacol 2000; 22: 609-13
10. 1, Two new alkaloids exhibiting marked anticholinesterase activity. Can J Chem 1986; 64: 837-9
11. Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C and the Galantamine USA-10 Study Group. A 5-month, randomized, placebo-controlled trial of galanthamine in AD. Neurology 2000; 54: 2269-75
12. Raskind MA, Peskind ER, Wessel T, Yuan W and the Galantamine USA-1 Study Group. A randomized, placebo-controlled trial with a 6-month extension. Neurology 2000; 54: 2261-8
13. Pauli GF. Comprehensive spectroscopic investigation of α-onocerin. Planta Med 2000; 66: 299-302
14. 1 On the constituents of Lycopodium cernuum and Lycopodium inundatum L. Yakugaku Zasshi 1971; 91: 980-6
15. Cai X, Pan DJ, Xu GY. Studies on the tetracyclic triterpenes of Lycopodium obscurum L. Acta Chim Sin 1989; 47: 1025-8
16. Cai X, Pan DJ, Xu GY, Seto H, Furihata K. Novel pentacyclic triterpene esters of serratene type from Lycopodium obscurum L. Acta Chim Sin 1992; 50: 60-6
17. Trofimova NN, Gromova AS, Semenov AA. Serratene Triterpenoids from Lycopodium clavatum L. (Lycopodiaceae). Russian Chem Bull 1996; 45: 961-3
18. Ellman GL. Colorimetric method for determining low concentrations of mercaptans. Arch Biochem Biophys 1958; 74: 443-50
19. Ellman GL, Courtney D, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95
20. Sugimoto H, Ogura H, Arai Y, Iimura Y, Yamanishi Y. Research and development of donepezil hydrochloride, A new type of acetylcholinesterase inhibitor. Jpn J Pharmacol 2002; 89: 7-20